Fundraising Fox

Imvaria San Francisco

Berkeley, US · Founded 2019 · 8 employees on LinkedIn · 3 known investors

Find your way into Imvaria San Francisco

1,168 people in our graph share verified history with the Imvaria San Francisco team — schools, employers, funds. One of them is your warm intro.

IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.

Founders & leadership

Imvaria San Francisco was founded in 2019 by Joshua Reicher and Michael Muelly.

JR
Joshua ReicherinCo-founder & CEO
MMMichael Muelly
Michael MuellyinCo-founder & CTODr. Michael Muelly is Co-founder and CTO of IMVARIA, which develops AI software for analyzing medical imaging to diagnose lung diseases. He holds expertise in radiology and computer science.

Investors · 3

Competitors · 4

by search overlap

Companies competing with Imvaria San Francisco for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Imvaria San Francisco do?
IMVARIA develops AI-driven software-as-medical-device solutions that analyze medical imaging and data to provide non-invasive diagnostic assessments for lung diseases, including idiopathic pulmonary fibrosis and interstitial lung disease. The company's FDA-authorized tools serve pulmonologists and other clinicians to reduce the need for invasive biopsy testing.
Who founded Imvaria San Francisco?
Imvaria San Francisco was founded by Joshua Reicher, Michael Muelly in 2019.
Who are Imvaria San Francisco's investors?
Imvaria San Francisco's investors include Creative Ventures, InHealth Ventures, Meridian Street Capital.
Where is Imvaria San Francisco headquartered?
Imvaria San Francisco is headquartered in Berkeley, US.